世界の失禁ケア製品市場は、2025年の148億1000万ドルから2030年には208億5000万ドルに達し、CAGRは7.1%になると予想されます。市場で活動している著名なプレーヤーには、Essity Aktiebolag(スウェーデン)、Kimberly-Clark Corporation(米国)、The Procter & Gamble Company(米国)、PAUL HARTMANN AG(ドイツ)、Ontex BV(ベルギー)、ユニ・チャーム株式会社(日本)、Coloplast A/S(デンマーク)、Cardinal Health, Inc(米国)、Medline Industries, LP(米国)、McKesson Corporation(米国)、ABENA A/S(デンマーク)、Attindas Hygiene Partners Group(米国)、 Hollister Incorporated(米国)、Dynarex Corporation(米国)。
目次
TABLE OF CONTENTS
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY RESEARCH
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Primary sources
2.1.2.2 Key data from primary sources
2.1.2.3 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Approach 1: Company revenue estimation approach
2.2.1.2 Approach 2: Presentations of companies and primary interviews
2.2.1.3 Growth forecast
2.2.2 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
2.4 MARKET SHARE ANALYSIS
2.5 RESEARCH ASSUMPTIONS
2.5.1 PARAMETRIC ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.7 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 INCONTINENT CARE PRODUCTS MARKET OVERVIEW
4.2 EUROPE: INCONTINENT CARE PRODUCTS MARKET, BY PRODUCT (2024)
4.3 GEOGRAPHIC GROWTH OPPORTUNITIES
4.4 INCONTINENT CARE PRODUCTS MARKET: GEOGRAPHICAL MIX
4.5 INCONTINENT CARE PRODUCTS MARKET: EMERGING VS. DEVELOPED MARKETS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing geriatric population and subsequent rise in chronic conditions
5.2.1.2 High prevalence of incontinence
5.2.1.3 Growing importance & awareness of personal hygiene
5.2.1.4 Rapid urbanization and rising disposable income
5.2.1.5 Increasing cases of obesity
5.2.2 RESTRAINTS
5.2.2.1 Social stigma associated with incontinence care products
5.2.2.2 Environmental concerns related to disposal of incontinence products
5.2.3 OPPORTUNITIES
5.2.3.1 Development of bio-based superabsorbent polymers
5.2.3.2 Increasing adoption of smart diapers
5.2.3.3 Expansion of home healthcare
5.2.4 CHALLENGES
5.2.4.1 Underreporting of fecal incontinence
5.2.4.2 Disparities in reimbursement for incontinence care products
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
5.4 PRICING ANALYSIS
5.4.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER, 2022-2O24
5.4.2 AVERAGE SELLING PRICE TREND, BY REGION, 2022-2024
5.4.3 AVERAGE SELLING PRICE TREND, BY PRODUCT
5.5 VALUE CHAIN ANALYSIS
5.5.1 RESEARCH & PRODUCT DEVELOPMENT
5.5.2 RAW MATERIAL PROCUREMENT
5.5.3 MANUFACTURING
5.5.4 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
5.6 SUPPLY CHAIN ANALYSIS
5.6.1 PROMINENT COMPANIES
5.6.2 SMALL & MEDIUM-SIZED ENTERPRISES
5.6.3 END USERS
5.7 TECHNOLOGY ANALYSIS
5.7.1 KEY TECHNOLOGIES
5.7.1.1 Super Absorbent Polymers (SAPs)
5.7.2 COMPLEMENTARY TECHNOLOGIES
5.7.2.1 Sensor technology
5.8 PATENT ANALYSIS
5.9 TRADE ANALYSIS
5.9.1 TRADE ANALYSIS FOR INCONTINENT CARE PRODUCTS (ABSORBENTS)
5.9.1.1 Import data for HS code 961900
5.9.1.2 Export data for HS code 961900
5.9.2 TRADE ANALYSIS FOR INCONTINENT CARE PRODUCTS (NON-ABSORBENTS)
5.9.2.1 Import data for HS code 901839
5.9.2.2 Export data for HS code 901839
5.10 KEY CONFERENCES & EVENTS, 2025-2026
5.11 REGULATORY ANALYSIS
5.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.11.2 REGULATORY LANDSCAPE
5.11.2.1 North America
5.11.2.1.1 US
5.11.2.1.2 Canada
5.11.2.2 Europe
5.11.2.3 Asia Pacific
5.11.2.3.1 China
5.11.2.3.2 Japan
5.11.2.3.3 India
5.11.2.3.4 South Korea
5.11.2.4 Latin America
5.11.2.4.1 Brazil
5.11.2.4.2 Mexico
5.11.2.5 Middle East
5.11.2.6 Africa
5.12 PORTER'S FIVE FORCES ANALYSIS
5.12.1 INTENSITY OF COMPETITIVE RIVALRY
5.12.2 BARGAINING POWER OF SUPPLIERS
5.12.3 BARGAINING POWER OF BUYERS
5.12.4 THREAT FROM SUBSTITUTES
5.12.5 THREAT FROM NEW ENTRANTS
5.13 KEY STAKEHOLDERS & BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.13.2 BUYING CRITERIA
5.14 IMPACT OF AI/GENERATIVE AI ON INCONTINENT CARE PRODUCTS MARKET
5.14.1 INTRODUCTION
5.14.2 POTENTIAL OF AI IN INCONTINENT CARE PRODUCTS MARKET
5.14.3 AI USE CASES
5.14.4 KEY COMPANIES IMPLEMENTING AI
5.14.5 FUTURE OF GENERATIVE AI ON INCONTINENT CARE PRODUCTS MARKET
5.15 TRUMP TARIFF IMPACT ON INCONTINENT CARE PRODUCTS MARKET
5.15.1 INTRODUCTION
5.15.2 KEY TARIFF RATES
5.15.3 IMPACT OF TARIFFS ON PRICING
5.15.4 KEY IMPACT ON VARIOUS REGIONS
5.15.4.1 North America
5.15.4.2 Europe
5.15.4.3 Asia Pacific
5.15.5 END-USER INDUSTRY IMPACT
6 INCONTINENT CARE PRODUCTS MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 ABSORBENTS
6.2.1 PADS & GUARDS
6.2.1.1 Ease of use to drive market
6.2.2 UNDERWEAR & BRIEFS
6.2.2.1 Increased absorbency to fuel demand
6.2.3 BED PROTECTORS
6.2.3.1 Gradual shift towards home-based care to fuel demand
6.2.4 OTHER ABSORBENTS
6.3 NON-ABSORBENTS
6.3.1 CATHETERS
6.3.1.1 Intermittent catheters
6.3.1.1.1 Reduced risk of infections to boost market
6.3.1.2 Indwelling catheters
6.3.1.2.1 Rising usage by critically ill patients to boost demand
6.3.1.3 External catheters
6.3.1.3.1 Ease of use to boost demand
6.3.2 DRAINAGE BAGS
6.3.2.1 Increasing rates of catheterization to support market uptake
6.3.3 STIMULATION DEVICES
6.3.3.1 Growing use in home settings to drive market
6.3.4 OTHER NON-ABSORBENTS
7 INCONTINENT CARE PRODUCTS MARKET, BY TYPE
7.1 INTRODUCTION
7.2 URINARY INCONTINENCE
7.2.1 GROWING PREVALENCE AMONG WOMEN TO DRIVE MARKET
7.3 FECAL INCONTINENCE
7.3.1 INCREASE IN GERIATRIC POPULATION TO SUPPORT MARKET GROWTH
8 INCONTINENT CARE PRODUCTS MARKET, BY USAGE
8.1 INTRODUCTION
8.2 DISPOSABLE
8.2.1 EASY AVAILABILITY AND CONVENIENCE TO DRIVE MARKET
8.3 REUSABLE
8.3.1 ENVIRONMENTAL SUSTAINABILITY TO FUEL DEMAND
9 INCONTINENT CARE PRODUCTS MARKET, BY GENDER
9.1 INTRODUCTION
9.2 FEMALE
9.2.1 HIGHER RATE OF INCONTINENCE DUE TO HORMONAL CHANGES TO PROPEL MARKET
9.3 MALE
9.3.1 RISING PREVALENCE OF BPH TO SUPPORT MARKET GROWTH
10 INCONTINENT CARE PRODUCTS MARKET, BY END USER
10.1 INTRODUCTION
10.2 HOME CARE
10.2.1 COST-EFFICIENCY AND HIGH COMFORT TO PROPEL MARKET
10.3 HOSPITALS & AMBULATORY SURGERY CENTERS (ASCS)
10.3.1 AVAILABILITY OF CRITICAL CARE SERVICES TO DRIVE DEMAND
10.4 OTHER END USERS
11 INCONTINENT CARE PRODUCTS MARKET, BY REGION
11.1 INTRODUCTION
11.2 EUROPE
11.2.1 MACROECONOMIC OUTLOOK FOR EUROPE
11.2.2 GERMANY
11.2.2.1 Growing incidence of neurological conditions to boost demand
11.2.3 UK
11.2.3.1 High prevalence of chronic diseases to drive market
11.2.4 FRANCE
11.2.4.1 Large target population to support market growth
11.2.5 ITALY
11.2.5.1 Growing awareness initiatives for urinary & fecal incontinence to fuel market
11.2.6 SPAIN
11.2.6.1 Increasing prevalence of CKD to drive market
11.2.7 REST OF EUROPE
11.3 NORTH AMERICA
11.3.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
11.3.2 US
11.3.2.1 Rising prevalence of incontinence to drive market
11.3.3 CANADA
11.3.3.1 High incidence of Alzheimer's disease to fuel market
11.4 ASIA PACIFIC
11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
11.4.2 CHINA
11.4.2.1 Rising prevalence of incontinence among women to propel market
11.4.3 JAPAN
11.4.3.1 Established healthcare system and favorable reimbursements to drive market
11.4.4 INDIA
11.4.4.1 R&D initiatives on innovative product development to boost market
11.4.5 SOUTH KOREA
11.4.5.1 Increasing prevalence of Urinary incontinence to boost market
11.4.6 REST OF ASIA PACIFIC
11.5 LATIN AMERICA
11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
11.5.2 BRAZIL
11.5.2.1 Advancements in ICP products to support market uptake
11.5.3 MEXICO
11.5.3.1 Rising prevalence of fecal incontinence to support market growth
11.5.4 REST OF LATIN AMERICA
11.6 MIDDLE EAST & AFRICA
11.6.1 IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH
11.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN INCONTINENT CARE PRODUCTS MARKET
12.3 REVENUE ANALYSIS, 2022-2024
12.4 MARKET SHARE ANALYSIS, 2024
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
12.5.5.1 Company footprint
12.5.5.2 Region footprint
12.5.5.3 Product footprint
12.5.5.4 Type footprint
12.5.5.5 End-user footprint
12.6 COMPANY EVALUATION MATRIX: SMES/STARTUPS, 2024
12.6.1 PROGRESSIVE COMPANIES
12.6.2 STARTING BLOCKS
12.6.3 RESPONSIVE COMPANIES
12.6.4 DYNAMIC COMPANIES
12.7 COMPETITIVE SCENARIO
12.7.1 PRODUCT LAUNCHES
12.7.2 DEALS
12.7.3 EXPANSIONS
13 COMPANY PROFILES
13.1 KEY PLAYERS
13.1.1 ESSITY AKTIEBOLAG
13.1.1.1 Business overview
13.1.1.2 Products offered
13.1.1.3 Recent developments
13.1.1.3.1 Product launches
13.1.1.3.2 Deals
13.1.1.4 MnM view
13.1.1.4.1 Key strengths
13.1.1.4.2 Strategic choices
13.1.1.4.3 Weaknesses & competitive threats
13.1.2 KIMBERLY-CLARK CORPORATION
13.1.2.1 Business overview
13.1.2.2 Products offered
13.1.2.3 Recent developments
13.1.2.3.1 Product launches
13.1.2.3.2 Deals
13.1.2.3.3 Expansions
13.1.2.4 MnM view
13.1.2.4.1 Key strengths
13.1.2.4.2 Strategic choices
13.1.2.4.3 Weaknesses & competitive threats
13.1.3 THE PROCTER & GAMBLE COMPANY
13.1.3.1 Business overview
13.1.3.2 Products offered
13.1.3.3 MnM view
13.1.3.3.1 Key strengths
13.1.3.3.2 Strategic choices
13.1.3.3.3 Weaknesses & competitive threats
13.1.4 ONTEX BV
13.1.4.1 Business overview
13.1.4.2 Products offered
13.1.4.3 Recent developments
13.1.4.3.1 Product launches
13.1.4.3.2 Expansions
13.1.4.4 MnM view
13.1.4.4.1 Key strengths
13.1.4.4.2 Strategic choices
13.1.4.4.3 Weaknesses & competitive threats
13.1.5 PAUL HARTMANN AG
13.1.5.1 Business overview
13.1.5.2 Products offered
13.1.5.3 MnM view
13.1.5.3.1 Key strengths
13.1.5.3.2 Strategic choices
13.1.5.3.3 Weaknesses & competitive threats
13.1.6 COLOPLAST A/S
13.1.6.1 Business overview
13.1.6.2 Products offered
13.1.6.3 Recent developments
13.1.6.3.1 Product launches
13.1.6.3.2 Expansions
13.1.7 UNICHARM CORPORATION
13.1.7.1 Business overview
13.1.7.2 Products offered
13.1.7.3 Recent developments
13.1.7.3.1 Product launches
13.1.8 CARDINAL HEALTH, INC
13.1.8.1 Business overview
13.1.8.2 Products offered
13.1.8.3 Recent developments
13.1.8.3.1 Expansions
13.1.9 MEDLINE INDUSTRIES, LP
13.1.9.1 Business overview
13.1.9.2 Recent developments
13.1.9.2.1 Deals
13.1.10 MCKESSON CORPORATION
13.1.10.1 Business overview
13.1.10.2 Products offered
13.1.11 ABENA A/S
13.1.11.1 Business overview
13.1.11.2 Products offered
13.1.11.3 Recent developments
13.1.11.3.1 Expansions
13.1.12 ATTINDAS HYGIENE PARTNERS GROUP
13.1.12.1 Business overview
13.1.12.2 Products offered
13.1.12.3 Recent developments
13.1.12.3.1 Product launches
13.1.13 HOLLISTER INCORPORATED
13.1.13.1 Business overview
13.1.13.2 Products offered
13.1.13.3 Recent developments
13.1.13.3.1 Expansions
13.1.14 DYNAREX CORPORATION
13.1.14.1 Business overview
13.1.14.2 Products offered
13.2 OTHER PLAYERS
13.2.1 CONVATEC GROUP PLC
13.2.2 BECTON, DICKINSON AND COMPANY
13.2.3 DENTSPLY SIRONA
13.2.4 STRYKER CORPORATION
13.2.5 FIRST QUALITY ENTERPRISES, INC.
13.2.6 PRINCIPLE BUSINESS ENTERPRISES, INC.
13.2.7 TZMO SA
13.2.8 PRIMARE INTERNATIONAL LTD.
13.2.9 DRYLOCK TECHNOLOGIES
13.2.10 NORTHSHORE CARE SUPPLY
13.2.11 NOBEL HYGIENE PVT. LTD.
14 APPENDIX
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS n
